Globus Medical
GMED
377 hedge funds and large institutions have $5.08B invested in Globus Medical in 2022 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 146 increasing their positions, 112 reducing their positions, and 37 closing their positions.
270% more call options, than puts
Call options by funds: $19.1M | Put options by funds: $5.17M
30% more repeat investments, than reductions
Existing positions increased: 146 | Existing positions reduced: 112
16% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 37
1.39% more ownership
Funds ownership: 86.48% → 87.87% (+1.4%)
1% more funds holding
Funds holding: 373 → 377 (+4)
5% more capital invested
Capital invested by funds: $4.85B → $5.08B (+$222M)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$59.1M |
| 2 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$33.8M |
| 3 |
Nordea Investment Management
Stockholm,
Sweden
|
+$11.3M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$10.4M |
| 5 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
+$10.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$38.9M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$18.5M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$16.6M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$12.4M |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$11.3M |
GMED Hedge Fund Activity: Q1 2022 in Review
377 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q1 2022, worth a combined $5.08B — up 4.6% from $4.85B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new GMED positions and 37 closed out — a net gain of 6 holders — while 146 added to existing stakes and 112 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $59.1M. The largest seller was Norges Bank, cutting an estimated $38.9M.
- 377 institutional investors held Globus Medical (GMED) as of Q1 2022, up from 373 in Q4 2021.
- Funds reported $5.08B of Globus Medical stock for Q1 2022, up 4.6% quarter-over-quarter.
- 43 funds opened new Globus Medical positions in Q1 2022 and 37 closed out, a net change of +6 holders.
- The largest Globus Medical buyer in Q1 2022 was Morgan Stanley, an estimated $59.1M added.
- The largest Globus Medical seller in Q1 2022 was Norges Bank, an estimated $38.9M sold.
Based on aggregated 13F filings for Q1 2022.